Community pharmacist targeted screening for chronic kidney disease

Canadian Pharmacists Journal

Volumn 149, Issue 1, 2016, Pages 13-17

  Al Hamarneh, Yazid N ^a   Hemmelgarn, Brenda ^b   Curtis, Craig ^c   Balint, Carlee ^d   Jones, Charlotte A ^e   Tsuyuki, Ross T ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c ALBERTA HEALTH SERVICES   (Canada)

^d FOOTHILLS HOSPITAL   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AWARENESS; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHARMACIST; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SCREENING; SELF REPORT;

EID: 84954417566     PISSN: 17151635     EISSN: 1913701X     Source Type: Journal    
DOI: 10.1177/1715163515618421     Document Type: Article

References (17)

1. P.AroraP.VasaD.Brenner. Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey. CMAJ2013;185:E417-23.
2. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl2013;3(1):1-150.
3. A.J.ZillichJ.J.SaseenR.M.Dehart. Caring for patients with chronic kidney disease: a joint opinion of the ambulatory care and the nephrology practice and research networks of the American College of Clinical Pharmacy. Pharmacotherapy2005;25:123-42.
4. T.H.JafarC.H.SchmidM.Landa. Angiotensin converting enzyme inhibitors and progression of nondiabetic renal disease: a meta-analysis of patient-level data. Ann Intern Med2001;135:73-87.
5. E.J.LewisL.G.HunsickerW.R.Clarke. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med2001;345:851-60.
6. J.T.WrightJrG.BakrisT.GreeneL.Y.AgodoaEffect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK Trial. JAMA2002;288:2421-31.
7. P.K.MitraJ.R.BradleyChronic kidney disease in primary care. J R Soc Med2007;100:40-5.
8. C.CurtisC.BalintY.N.Al Hamarneh. Online clinical pathway for managing adults with chronic kidney disease. Can Pharm J (Ott)2015;148:257-62.
9. Kidney Disease: Improving Global Outcomes (KDIGO) Lipid Work Group. KDIGO clinical practice guideline for lipid management in chronic kidney disease. Kidney Int Suppl2013;3(3):1-305.
10. S.TobeJ.StoneM.Brouwers. Harmonization of guidelines for the prevention and treatment of cardiovascular disease: the C-CHANGE Initiative. CMAJ2011;183:1135-50.
11. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes2013;37(Suppl 1):S1-212.
12. J.-F.TanguayA.D.BellM.L.Ackman. Focused 2012 update of the Canadian Cardiovascular Society Guidelines for the use of antiplatelet therapy. Can J Cardiol2013;29:1334-45.
13. T.J.AndersonJ.GrégoireR.A.Hegele. 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol2013;29:151-67.
14. D.G.HackamR.R.QuinnP.Ravani. The 2013 Canadian Hypertension Education Program (CHEP) recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol2013;29:528-42.
15. Y.N.Al HamarnehC.JonesB.HemmelgarnR.T.Tsuyuki. The Alberta vascular risk reduction community pharmacy project: RxEACH. 2015. Available:https://clinicaltrials.gov/ct2/show/NCT01979471 (accessed October 15, 2015).
16. Statistics Canada. Annual demographic estimates: Canada, provinces and territories. Population by age and sex, 2013. Available:www.statcan.gc.ca/pub/91-215-x/2012000/part-partie2-eng.htm (accessed September 23, 2015).
17. L.A.SzczechR.C.StewartH.L.Su. Primary care detection of chronic kidney disease in adults with type-2 diabetes: the ADD-CKD Study (awareness, detection and drug therapy in type 2 diabetes and chronic kidney disease). PLoS One2014;9:e110535.